Moreover, the effect of suppressingthe interaction between OX40 and its receptor hasbeen investigated for the treatment of many diseasesincluding asthma and allergy, atherosclerosis, diabetes,and systemic lupus erythematosus (SLE) (18-20). Here, TNFRSF4 is linked to atherosclerosis.